Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

76
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
76
Drug Therapy01:28

Drug Therapy

144
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
144
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

90
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
90
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

58
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
58
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

77
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
77
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

57
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
57

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodological Research Practices for the Adaptation of Measuring Instruments in Health Care: Protocol for a Scoping Review.

JMIR research protocols·2026
Same author

Implementation strategies by leaders and health professionals to improve the safety climate in the operating room: a scoping review.

BMJ open·2026
Same author

Incidents related to the duration of medical devices in Intensive Care: a cross-sectional study.

Revista brasileira de enfermagem·2025
Same author

Quality improvement project to reduce infection indicators in intensive care.

Revista gaucha de enfermagem·2025
Same author

Implementation strategies by leaders and health professionals to improve the safety climate in the operating room: a scoping review protocol.

BMJ open·2025
Same author

Analysis of omission of antimicrobial doses in Intensive Care Units.

Revista brasileira de enfermagem·2024

Related Experiment Video

Updated: Nov 10, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.8K

Medication time out as a strategy for patient safety: reducing medication errors.

Laís Lima Santos1, Flávia Giron Camerini1, Cíntia Silva Fassarella1

  • 1Universidade do Estado do Rio de Janeiro. Rio de Janeiro, Rio de Janeiro, Brazil.

Revista Brasileira De Enfermagem
|March 31, 2021
PubMed
Summary

The medication time out strategy effectively reduced medication errors in a cardiac intensive care unit. This process identified numerous potentially harmful drug errors, especially in patients with polypharmacy.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.1K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.1K

Related Experiment Videos

Last Updated: Nov 10, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.8K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.1K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.1K

Area of Science:

  • Clinical Pharmacy
  • Patient Safety
  • Healthcare Quality Improvement

Background:

  • Medication errors pose a significant threat to patient safety, particularly in critical care settings.
  • The medication time out strategy is a proposed intervention to mitigate these errors.
  • Implementing and evaluating such strategies is crucial for improving healthcare outcomes.

Purpose of the Study:

  • To analyze the implementation and effectiveness of the medication time out strategy in reducing medication errors.
  • To quantify the impact of the strategy on prescription accuracy and patient safety.
  • To assess the resource utilization associated with the medication time out strategy.

Main Methods:

  • A quantitative, cross-sectional, inferential study design was employed.
  • Direct observation was used to assess the implementation of the medication time out strategy.
  • The study was conducted in a cardiac intensive care unit of a university hospital.

Main Results:

  • 2,799 medications across 234 prescriptions were analyzed.
  • The medication time out strategy led to changes in 61% of prescriptions, altering 290 medications.
  • Potentially harmful medication errors were identified in 35.9% of altered medications, with polypharmacy increasing error risk (p=0.031).

Conclusions:

  • The medication time out strategy demonstrated significant contribution to intercepting medication errors.
  • The strategy proved effective with minimal human and material resource investment.
  • This highlights the value of structured safety protocols in preventing adverse drug events.